138 related articles for article (PubMed ID: 26323947)
1. Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
MacLennan S; Williamson PR; Lam TB
Eur Urol; 2015 Dec; 68(6):e123-4. PubMed ID: 26323947
[No Abstract] [Full Text] [Related]
2. Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
Martin NE; Stowell C; Huland H
Eur Urol; 2015 Dec; 68(6):e125-6. PubMed ID: 26320381
[No Abstract] [Full Text] [Related]
3. Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
Wittmann D; Skolarus TA
Eur Urol; 2016 Jun; 69(6):e125-6. PubMed ID: 26873838
[No Abstract] [Full Text] [Related]
4. Reply to Daniela Wittmann, Ted A. Skolarus' Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2014;67:460-7.
Martin NE; Stowell C
Eur Urol; 2016 Jun; 69(6):e127. PubMed ID: 26873843
[No Abstract] [Full Text] [Related]
5. Defining a standard set of patient-centered outcomes for men with localized prostate cancer.
Martin NE; Massey L; Stowell C; Bangma C; Briganti A; Bill-Axelson A; Blute M; Catto J; Chen RC; D'Amico AV; Feick G; Fitzpatrick JM; Frank SJ; Froehner M; Frydenberg M; Glaser A; Graefen M; Hamstra D; Kibel A; Mendenhall N; Moretti K; Ramon J; Roos I; Sandler H; Sullivan FJ; Swanson D; Tewari A; Vickers A; Wiegel T; Huland H
Eur Urol; 2015 Mar; 67(3):460-7. PubMed ID: 25234359
[TBL] [Abstract][Full Text] [Related]
6. Standardization of patient-centered outcomes: less is more.
Ehdaie B; Eastham JA
Eur Urol; 2015 Mar; 67(3):468-9. PubMed ID: 25449205
[No Abstract] [Full Text] [Related]
7. Quality of care indicators for prostate cancer: progress toward consensus.
Miller DC; Saigal CS
Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
[TBL] [Abstract][Full Text] [Related]
8. Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.
Goonewardene SS; Persad R; Young A; Makar A
Eur Urol; 2014 Sep; 66(3):e51-2. PubMed ID: 24813269
[No Abstract] [Full Text] [Related]
9. Patient Centeredness and Engagement in Quality-of-Care Oncology Research.
Clauser SB; Gayer C; Murphy E; Majhail NS; Baker KS
J Oncol Pract; 2015 May; 11(3):176-9. PubMed ID: 25852140
[TBL] [Abstract][Full Text] [Related]
10. ["Expanded prostate cancer index composite" (EPIC-26): Results of functional treatment in patients with localized prostate cancer].
Beyer B; Huland H; Feick G; Graefen M
Urologe A; 2015 Nov; 54(11):1591-5. PubMed ID: 26347350
[TBL] [Abstract][Full Text] [Related]
11. [Indicator analysis of prostate cancer centers certified by the German Cancer Society 2015].
Fichtner J; Kowalski C; Wesselmann S; Albers P
Urologe A; 2015 Nov; 54(11):1530, 1532-6. PubMed ID: 26573670
[TBL] [Abstract][Full Text] [Related]
12. Development of Indicators to Assess Quality of Care for Prostate Cancer.
Nag N; Millar J; Davis ID; Costello S; Duthie JB; Mark S; Delprado W; Smith D; Pryor D; Galvin D; Sullivan F; Murphy ÁC; Roder D; Elsaleh H; Currow D; White C; Skala M; Moretti KL; Walker T; De Ieso P; Brooks A; Heathcote P; Frydenberg M; Thavaseelan J; Evans SM
Eur Urol Focus; 2018 Jan; 4(1):57-63. PubMed ID: 28753751
[TBL] [Abstract][Full Text] [Related]
13. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.
Alemozaffar M; Sanda M; Yecies D; Mucci LA; Stampfer MJ; Kenfield SA
Eur Urol; 2015 Mar; 67(3):432-8. PubMed ID: 24582327
[TBL] [Abstract][Full Text] [Related]
14. How to Use Quality Improvement Tools in Clinical Practice: A Primer for Nephrologists.
Chan CT; Chertow GM; Nesrallah G; Bell CM
Clin J Am Soc Nephrol; 2016 May; 11(5):891-892. PubMed ID: 27016499
[No Abstract] [Full Text] [Related]
15. Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management.
Sampurno F; Zheng J; Di Stefano L; Millar JL; Foster C; Fuedea F; Higano C; Hulan H; Mark S; Moore C; Richardson A; Sullivan F; Wenger NS; Wittmann D; Evans S
J Urol; 2018 Aug; 200(2):319-326. PubMed ID: 29477721
[TBL] [Abstract][Full Text] [Related]
16. Quality assessment in oncology.
Albert JM; Das P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):773-81. PubMed ID: 22445001
[TBL] [Abstract][Full Text] [Related]
17. Re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214-20.
Yuan R; Huang H
Eur Urol; 2017 May; 71(5):e147. PubMed ID: 27836417
[No Abstract] [Full Text] [Related]
18. ACOS cancer standards affect how you practice as an oncology nurse.
Merenda C
ONS Connect; 2013 Mar; 28(1):15. PubMed ID: 23495520
[No Abstract] [Full Text] [Related]
19. Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
Parker C; Sydes MR; Kynaston H;
Eur Urol; 2013 Nov; 64(5):e102. PubMed ID: 23953599
[No Abstract] [Full Text] [Related]
20. Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.
Morgans AK; van Bommel AC; Stowell C; Abrahm JL; Basch E; Bekelman JE; Berry DL; Bossi A; Davis ID; de Reijke TM; Denis LJ; Evans SM; Fleshner NE; George DJ; Kiefert J; Lin DW; Matthew AG; McDermott R; Payne H; Roos IA; Schrag D; Steuber T; Tombal B; van Basten JP; van der Hoeven JJ; Penson DF;
Eur Urol; 2015 Nov; 68(5):891-8. PubMed ID: 26129856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
